KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (2019 - 2025)

Historic Interest Coverage Ratio for Rigel Pharmaceuticals (RIGL) over the last 10 years, with Q3 2025 value amounting to 15.01.

  • Rigel Pharmaceuticals' Interest Coverage Ratio rose 11991.23% to 15.01 in Q3 2025 from the same period last year, while for Sep 2025 it was 15.7, marking a year-over-year increase of 120029.57%. This contributed to the annual value of 3.06 for FY2024, which is 20246.52% up from last year.
  • Per Rigel Pharmaceuticals' latest filing, its Interest Coverage Ratio stood at 15.01 for Q3 2025, which was up 11991.23% from 32.61 recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Interest Coverage Ratio ranged from a high of 86.09 in Q1 2021 and a low of 22.79 during Q2 2022
  • Over the past 5 years, Rigel Pharmaceuticals' median Interest Coverage Ratio value was 2.35 (recorded in 2023), while the average stood at 1.78.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first crashed by 20717.24% in 2022, then skyrocketed by 1470019.61% in 2025.
  • Quarter analysis of 5 years shows Rigel Pharmaceuticals' Interest Coverage Ratio stood at 16.49 in 2021, then surged by 111.39% to 1.88 in 2022, then plummeted by 45.11% to 1.03 in 2023, then soared by 726.35% to 8.52 in 2024, then skyrocketed by 76.14% to 15.01 in 2025.
  • Its last three reported values are 15.01 in Q3 2025, 32.61 for Q2 2025, and 6.89 during Q1 2025.